EMAIL THIS PAGE TO A FRIEND

Chemosphere

Storage effect on the analysis of pharmaceuticals and personal care products in wastewater.


PMID 24997900

Abstract

In this study, the stability of 124 target analytes in influent and effluent wastewater samples during short-term (4°C) and long-term (-18°C) storage was assessed. The most common storage scenario was considered, in which samples were frozen immediately after sampling without any pre-treatment. During short-term storage more analytes remained stable (concentration during storage was in the range of 60-120% of the initial concentration) at 4°C than at -18°C. During long-term storage (-18°C), three types of behavior were observed: constant concentrations throughout the experimental period, decreasing concentrations with time, and loss of the compound from the sample after freezing. Differences between effluent and influent samples were observed for 50 out of 124 tested PPCPs. The amount of stable analytes decreased with time during long-term storage. 72% and 56% of the target compounds in the effluent and influent wastewater, respectively, remained stable during 60days of storage. The number of stable compounds decreased to 57 (46%) and 46 (37%) in the effluent and influent, respectively, over 120days. 15 Pharmaceuticals were lost after freezing/thawing cycle. The results stress the importance of storage factors during analysis of pharmaceuticals in wastewater. The stability of target compounds in the samples under the planned storage conditions should be checked before starting the experiment to obtain reliable data.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C4024
Carbamazepine, powder
C15H12N2O
94496
Carbamazepine, analytical standard
C15H12N2O
C8981
Carbamazepine, meets USP testing specifications
C15H12N2O
C0450000
Carbamazepine, European Pharmacopoeia (EP) Reference Standard
C15H12N2O
1093001
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
C15H12N2O
PHR1067
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
C15H12N2O
S7507
Sulfamethoxazole, analytical standard
C10H11N3O3S
76177
Sulfamethoxazole, certified reference material, TraceCERT®
C10H11N3O3S
31737
Sulfamethoxazole, VETRANAL, analytical standard
C10H11N3O3S
PHR1126
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
C10H11N3O3S
1631001
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
C10H11N3O3S
S2100000
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard
C10H11N3O3S
T7883
Trimethoprim, ≥98% (HPLC)
C14H18N4O3
46984
Trimethoprim, VETRANAL, analytical standard
C14H18N4O3
92131
Trimethoprim, crystallized, ≥99.0% (HPLC)
C14H18N4O3
PHR1056
Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material
C14H18N4O3
1692505
Trimethoprim, United States Pharmacopeia (USP) Reference Standard
C14H18N4O3
T2200000
Trimethoprim, European Pharmacopoeia (EP) Reference Standard
C14H18N4O3
Y0000684
Trimethoprim for system suitability, European Pharmacopoeia (EP) Reference Standard
C14H18N4O3